The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.
💡 한 문장 핵심
암 말기에만 국한하지 않고 암 치료 전 과정에서 한의학을 보조요법으로 활용하는 것의 이점
4/5 보강
TL;DR
Current evidence for using TCM as adjuvant cancer treatment in different stages of cancer lesions is summarized to contribute to an understanding of Chinese herbal medicines as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.
연도별 인용 (2015–2026) · 합계 478
OpenAlex 토픽 ·
Ginseng Biological Effects and Applications
Traditional Chinese Medicine Analysis
Plant-based Medicinal Research
Abstract 🌐 Abstract
Recent studies indicate that Traditional Chinese medicine (TCM) can play an important role in the whole course of cancer treatment such as recovery stages of post-operative, radiotherapy or chemotherapy stages instead of only terminal stage of cancer. In this review, we have summarized current evidence for using TCM as adjuvant cancer treatment in different stages of cancer lesions. Some TCMs (e.g., TJ-41, Liu-jun-zi-tang, PHY906, Coumarin, and Aescine) are capable of improving the post-operative symptoms such as fatigue, pain, appetite, diarrhea, nausea, vomiting, and lymphedema. Some TCMs (e.g., Ginseng, Huang-Qi, BanZhiLian, TJ-48, Huachansu injection, Shenqi fuzheng injection, and Kanglaite injection) in combination with chemo- or radio-therapy are capable of enhancing the efficacy of and diminishing the side effects and complications caused by chemo- and radiotherapy. Taken together, they have great advantages in terms of suppressing tumor progression, relieving surgery complications, increasing the sensitivity of chemo- and radio- therapeutics, improving an organism's immune system function, and lessening the damage caused by surgery, chemo- or radio-therapeutics. They have significant effects on relieving breast cancer-related lymphedema, reducing cancer-related fatigue and pain, improving radiation pneumonitis and gastrointestinal side effects, protecting liver function, and even ameliorating bone marrow suppression. This review of those medicines should contribute to an understanding of Chinese herbal medicines as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer, by providing useful information for development of more effective anti-cancer drugs and making more patients "survival with cancer" for a long time.
Current evidence for using TCM as adjuvant cancer treatment in different stages of cancer lesions is summarized to contribute to an understanding of Chinese herbal medicines as an adjunctive therapy i
APA 7
Qi, F., Zhao, L., Zhou, A., Zhang, B., Li, A., Wang, Z., & Han, J. (2015). The advantages of using traditional chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.. Bioscience trends, 9(1), 16-34. https://doi.org/10.5582/bst.2015.01019
Vancouver
Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Bioscience trends. 2015;9(1):16-34. doi:10.5582/bst.2015.01019
AMA 11
Qi F, Zhao L, Zhou A, Zhang B, Li A, Wang Z, et al. The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer. Bioscience trends. 2015;9(1):16-34. doi:10.5582/bst.2015.01019
Chicago
Qi, F., Zhao, L., Zhou, A., Zhang, B., Li, A., Wang, Z., and Han, J.. 2015. "The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer." Bioscience trends 9 (1): 16-34. https://doi.org/10.5582/bst.2015.01019
MLA 9
Qi, F., et al. "The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer." Bioscience trends, vol. 9, no. 1, 2015, pp. 16-34. doi:10.5582/bst.2015.01019.
PMID
25787906 ↗
추출된 의학 개체 (NER)
전체 NER 표 보기
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 1 | |
| 해부 | BanZhiLian
|
scispacy | 1 | ||
| 해부 | liver
|
간 | scispacy | 1 | |
| 합병증 | lymphedema
|
scispacy | 1 | ||
| 합병증 | gastrointestinal
|
위장관 | scispacy | 1 | |
| 약물 | ginseng
|
인삼 | dict | 1 | |
| 약물 | TCM
→ Traditional Chinese medicine
|
전통중의학(TCM) | scispacy | 1 | |
| 약물 | TJ-41
|
scispacy | 1 | ||
| 약물 | PHY906
|
scispacy | 1 | ||
| 약물 | Coumarin
|
scispacy | 1 | ||
| 약물 | Huachansu
|
scispacy | 1 | ||
| 약물 | Kanglaite
|
scispacy | 1 | ||
| 약물 | radio-
|
scispacy | 1 | ||
| 약물 | Aescine
|
scispacy | 1 | ||
| 약물 | TJ-48
|
scispacy | 1 | ||
| 약물 | chemo-
|
scispacy | 1 | ||
| 약물 | radio-therapy
|
scispacy | 1 | ||
| 질환 | anti-cancer
|
항암 | scispacy | 1 | |
| 질환 | cancer
|
암 | scispacy | 1 | |
| 질환 | TCM
→ Traditional Chinese medicine
|
전통중의학(TCM) | scispacy | 1 | |
| 질환 | cancer lesions
|
scispacy | 1 | ||
| 질환 | fatigue
|
scispacy | 1 | ||
| 질환 | pain
|
통증 | scispacy | 1 | |
| 질환 | appetite, diarrhea
|
scispacy | 1 | ||
| 질환 | nausea,
|
scispacy | 1 | ||
| 질환 | tumor
|
종양 | scispacy | 1 | |
| 질환 | breast cancer-related lymphedema
|
scispacy | 1 | ||
| 질환 | pneumonitis
|
scispacy | 1 | ||
| 질환 | bone marrow suppression
|
scispacy | 1 | ||
| 질환 | Liu-jun-zi-tang
|
scispacy | 1 | ||
| 기타 | patients
|
환자 | scispacy | 1 | |
| 기타 | Shenqi fuzheng
|
scispacy | 1 | ||
| 기타 | bone marrow
|
골수 | scispacy | 1 |
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🤖 이 논문을 인용한 AI 인사이트 · 2건
📰 주간
🏷 암·종양
인삼·진세노사이드 — 항암 면역 보조 부상
P: 전임상 종양 모델(in vitro/in vivo) 및 재배환경 비교용 인삼 원료가 주 대상이며, 표준화된 임상 환자집단보다 기초·전임상 연구가 O: 항암 면역조절 효과(microbiota 매개 면역관문억제제 감작, EV 매개 대식세포 재프로그래밍), 종양 억제, 생장·생합성 변화 및 원료 품
📰 주간
🏷 암·종양
인삼·한의약 — 암 면역요법 보조 잠재력
P: 암 환자 및 종양 동물·세포 모델. 임상 보조요법 대상 환자군과 미생물총-면역축·종양미세환경을 다루는 전임상 모델이 혼재되어 있습니다. O: 종양 크기, 면역세포 침윤, 삶의 질 등이며, 약동학·미생물총 바이오마커, 나노전달체의 표적성·안전성도 평가 지표로 거론됩니다.
이 논문은 위 AI 빅데이터 분석에 인용된 근거 논문입니다.
인용 관계
그래프 OA 노드: 1/1 (100%)
· 참조 0편 · 후속 1편
함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (5)
- Long non-coding RNA CATIP antisense RNA 1 (lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial-mesenchymal transition (EMT) pathway.
- Metal-Organic Frameworks for Precision Phototherapy of Breast Cancer.
- The laryngeal mask airway in the extraction of supernumerary teeth in children: a retrospective study.
- From Mechanism to Therapy: Isoliquiritigenin as a Novel Anti-Inflammatory Agent for Inflammatory Disease Management.
- Structure, performance and tissue repair evaluation of biodegradable core-sheath fiber patch loaded with curcumin nano-micelles.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
📖 비슷한 OA 논문 — 같은 카테고리, 무료 전문 가능
-
Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial.
TL;DRAmong women with stage I to II breast cancer receiving chemotherapy with a taxane, anthracycline, or both, those who underwent scalp cooling were significantly more likely to have …
-
Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis.
TL;DRThe results suggest that scalp cooling can prevent CIA in patients receiving chemotherapy, and the long‐term safety of scalp cooling should be confirmed in further studies.
-
Hair-Growth Potential of Ginseng and Its Major Metabolites: A Review on Its Molecular Mechanisms.
TL;DRA wide variety of structurally diverse classes of phytochemicals, including those present in ginseng, have demonstrated hair growth-promoting effects in a large number of preclinic…
-
Endocrine Therapy-Induced Alopecia in Patients With Breast Cancer.
TL;DREndocrine therapies are associated with a pattern alopecia similar to androgenetic-type, consistent with the mechanism of action of causal agents, and a significant negative impact…
-
Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer.
TL;DRAmong women undergoing non–anthracycline-based adjuvant chemotherapy for early-stage breast cancer, the use of scalp cooling vs no scalp cooling was associated with less hair loss …